LNC THERAPEUTICS
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies and clinical trials. Backed by leading venture capital investors, such as Seventure Partners (with the microbiome dedicated vehicle Health for Life Capital) and Family Offices, the company cultivates worldwide collaborations with renowned medical experts to ensure the highest level of standards in the development of innovative drugs. With a total of โฌ 16.5 million raised so far including โฌ 1.5 million grants from French BPI and Aquitaine Region, LNC Therapeutics will pursue its research programs to bring the next generation approach to treat obesity and cardiometabolic diseases.
LNC THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science
Founded:
2010-01-01
Address:
Bordeaux, Aquitaine, France
Country:
France
Website Url:
http://www.lnctherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+33557831503
Email Addresses:
[email protected]
Total Funding:
19.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Amazon Facebook Sharer CloudFront Google Adsense AWS Global Accelerator
Similar Organizations
The Brkfst Club
The Brkfst Club focuses on gathering like-minded individuals to invest in ground breaking ideas.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Venture Round - LNC Therapeutics
Seventure Partners
Seventure Partners investment in Series C - LNC Therapeutics
AQUITI Gestion
AQUITI Gestion investment in Series B - LNC Therapeutics
Seventure Partners
Seventure Partners investment in Series B - LNC Therapeutics
Blackstone Credit
Blackstone Credit investment in Series B - LNC Therapeutics
IRDI
IRDI investment in Series B - LNC Therapeutics
Official Site Inspections
http://www.lnctherapeutics.com Semrush global rank: 9.57 M Semrush visits lastest month: 139
- Host name: 104.21.70.36
- IP address: 104.21.70.36
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "LNC Therapeutics"
SNC Therapeutics, Inc.
SNC Therapeutics Inc. employs a disruptive drug and nonviral gene delivery platform technology for rational immunotherapy. Our synthetic nanocarriers (SNCs) permit scalable, versatile, and โฆSee details»
LNC Therapeutics - Crunchbase Company Profile & Funding
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases. All projects encompass fundamental research, preclinical studies โฆSee details»
LNC Therapeutics - VentureRadar
Website: https://lnctherapeutics.com. Develops therapeutic innovations utilizing gut microbiome potential, focusing on single strain live biotherapeutic products for obesity, metabolic diseases, โฆSee details»
LNC Therapeutics โข La French Tech Bordeaux
LNC Therapeutics est une société française de biotechnologie spécialisée dans la recherche et le développement de médicaments basés sur le fonctionnement du microbiome intestinal. Fondée en 2010, la société a pour but de développer โฆSee details»
LNC Therapeutics becomes YSOPIA Bioscience - NutraIngredients
Oct 1, 2020 The change comes as the firm received US approval this month for a Phase 1 trial looking into how a live single bacterial strain of Christensenella minuta could be used to โฆSee details»
SNC Therapeutics, Inc. | LinkedIn
SNC Therapeutics Inc. employs a disruptive drug and nonviral gene delivery platform technology for rational immunotherapy. Our synthetic nanocarriers (SNCs) permit scalable, versatile, and ...See details»
LNC Therapeutics Company Information - Funding, Investors, and โฆ
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
LNC Therapeutics - Overview, News & Similar companies - ZoomInfo
View LNC Therapeutics (www.lnctherapeutics.com) location in Nouvelle-Aquitaine, France , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
YSOPIA Bioscience (previously LNC Therapeutics) | VentureRadar
Similar Companies: XENO BIOSCIENCES INC. USA Privately Held Xeno Biosciences is a clinical-stage company focused on developing transformational therapies for metabolic โฆSee details»
LNC Therapeutics (Exclusive Worldwide License For Therapeutic ...
Information on acquisition, funding, investors, and executives for LNC Therapeutics (Exclusive Worldwide License For Therapeutic Application Of Christensenella). Use the PitchBook โฆSee details»
LNC Therapeutics - Company info. interviews, news
Founded in 2010, LNC Therapeutics is a French biotech company specialized in gut microbiome-based drug discovery. All of the company's projects include basic research, preclinical research and clinical trials.See details»
lncTAC 2025 Company Profile: Valuation, Funding & Investors
LncTAC General Information Description. Researcher and developer of lncRNA (Long noncoding RNA)-mediated chimeric technology intended for unmet clinical needs. The company develops โฆSee details»
LNC targets human trials this year as it steps up licencing and โฆ
May 7, 2020 French biotech LNC Therapeutics says it will launch the first ever in-human trials to dose with a single strain of Christensenella before the end of 2020, as the company looks to โฆSee details»
LNC Therapeutics forms advisory board for Christensenella research
LNC Therapeutics, a French biotech company specialising in gut microbiome-based drug research and discovery, has formed its Scientific Advisory Board (SAB), composed of โฆSee details»
LNC Therapeutics develops Christensenella therapy for mood
Apr 21, 2020 French biotech firm LNC Therapeutics is to enter into a licence agreement with the University of Valencia for a patent outlining the Christensenella gut bacteria's role in โฆSee details»
LNC Therapeutics - VentureRadar
Similar Companies: Azitra USA Private Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to โฆSee details»
LNC Therapeutics Licenses Microbiome Therapeutic to Treat Mood โฆ
Apr 17, 2020 The French microbiome biotech LNC Therapeutics has entered into a licensing agreement to use a specific strain of gut bacteria for the treatment of mood disorders such as โฆSee details»
LncRNAs: expanding horizons in drug development and disease โฆ
Feb 15, 2025 Affiliations 1 International School of Medicine, International Institutes of Medicine, The 4th Affiliated Hospital of Zhejiang University School of Medicine, Yiwu 322000, China; โฆSee details»
LNC Therapeutics Gets a Leg Up to Launch it Microbiome โฆ
Sep 28, 2017 The microbiome field is young yet, but itโs an area of great interest in therapeutics. Enterome recently sealed a deal with BMS in immuno-oncology, while Nestlé partnered with โฆSee details»
Snc Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Snc Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»